
LS Episode 504: Wife & Sweetheart (Feat. Chris Martin, Lynae Vanee & Shuga) podcast
Cam Newton Breaks Down NIL Money, Kaepernick’s Protest and Black Athlete Pressure | S3 Ep. 10 podcast
LS Episode 503: She The People (Feat. Terri J. Vaughn) podcast
THE BOYCOTT w/ Karlous, DC, & Clayton | 85 South Show Podcast podcast
Is Gay and Christian a Contradiction? Dr. David Johns EXPOSES Church Silence & LGBTQ Crisis| S3 Ep.9 podcast
In this episode of Market Mondays, we dive deep into the future of Eli Lilly as it potentially becomes the first trillion-dollar pharmaceutical company, fueled by the booming weight-loss drug market. We also explore the strategic showdown between Huawei and Apple as Huawei aims to challenge Apple by launching a new product just hours after the iPhone 16 unveiling.
We feature a segment from Ian's Invest Fest presentation, where he shares expert insights on becoming a successful trader.
Next, we discuss concerns about NVIDIA's market performance, analyze their recent earnings report, and evaluate the company's expansion into self-driving cars and networking businesses. We also address an ambitious $10 trillion valuation prediction for a tech giant and discuss NVIDIA's long-term strategy.
For personal finance enthusiasts, we offer advice on managing sudden wealth to ensure financial stability. We also cover the impact of market volatility in September, emerging market trends, Warren Buffett's investment strategy, and the looming recession risks based on the latest economic indicators.
Finally, we provide an earnings overview, highlighting Zscaler, Asana, Hormel, C3.ai, Dick’s, Dollar Tree, Shoe Carnival, Tilly’s, Nio, and DocuSign.
#MarketMondays #EliLilly #NVIDIA #Investing #HuaweiVsApple #PersonalFinance #WarrenBuffett #EmergingMarkets #TechStocks #Recession #StockMarket #IanDunlap #EarningsSeason
Support this podcast at — https://redcircle.com/marketmondays/donations
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
Copyright Blackpodcasting 2025